How should hypercalcemia secondary to primary hyperparathyroidism be treated?

Treatment of Hypercalcemia Secondary to Primary Hyperparathyroidism

Surgery (parathyroidectomy) is the definitive treatment for primary hyperparathyroidism and should be performed after stabilizing severe hypercalcemia with intravenous saline hydration and bisphosphonates 1, 2.

Immediate Management of Severe Hypercalcemia

Defining Severity

Severe hypercalcemia is defined as:

• Total calcium ≥3.5 mmol/L (≥140 mg/L or ≥14 mg/dL)
• Clinical manifestations: altered consciousness, dehydration with acute renal failure, severe acute pancreatitis, or threatening ECG changes 1, 3

Acute Treatment Algorithm

First-line therapy:

• Intravenous saline hydration is the cornerstone of initial management 1, 4. Volume expansion with isotonic saline during the first 24 hours, adapted to cardiac and renal function, should be initiated immediately 1.
• Research demonstrates that saline alone reduces calcium from 3.25 to 2.98 mmol/L over 3 days, though normalization does not occur 4.

Second-line therapy:

• Intravenous bisphosphonates (zoledronic acid or pamidronate) should be administered after blood and urine sampling for calcium and PTH assays 1. These are recommended for severe hypercalcemia unless contraindicated (e.g., pregnancy) 1.
• Zoledronic acid achieves a mean calcium reduction of 0.57 mmol/L, with normalization in 60% of patients 4.
• Doses must be adjusted for renal function 1.

Important caveat: Furosemide provides no additional benefit beyond saline hydration alone and may actually increase calcium levels (mean increase 0.09 mmol/L) 4. This contradicts older practices and should be avoided.

Third-line therapy:

• Denosumab can be used when bisphosphonates fail, are contraindicated, or in patients with severely impaired renal function 1, 5. Recent case reports demonstrate its efficacy in refractory cases 5.

Preoperative Stabilization

Target calcium <3.5 mmol/L (<140 mg/L) before surgery 1. Surgery should only proceed after stabilization of vital functions and treatment of major complications 1.

Correct vitamin D deficiency in patients with calcium <3.5 mmol/L to prevent postoperative hypocalcemia 1.

Definitive Surgical Management

Indications for Surgery

Surgery should be offered at diagnosis or during follow-up if ANY of the following criteria are present 2:

• Skeletal: T-score ≤-2.5 SD on bone densitometry at any site, or proven/low-energy fracture
• Renal: Proven renal colic, urolithiasis, nephrocalcinosis, OR eGFR <60 mL/min/1.73 m²
• Biochemical: 24-hour calciuria >250 mg/day (female) or >300 mg/day (male), OR calcium >10 mg/L (0.25 mmol/L) above upper normal limit
• Age: <50 years formally, adapted up to <70 depending on life expectancy 2

The 2025 French consensus emphasizes that surgery is the standard treatment for primary hyperparathyroidism when performed after proper preparation and preoperative localization 2.

Medical Management (Non-Surgical Candidates)

Pharmacological treatment is reserved for specific situations 2:

• Patient refuses surgery
• Not considered surgical candidate after multidisciplinary risk/benefit assessment
• Persistent disease after surgical exploration by trained team (case-by-case basis)

Medical options include:

• Calcimimetics (cinacalcet) for long-term calcium control 2, 6
• Bisphosphonates for skeletal protection 2

Critical limitation: No drug therapy has been shown to improve cognitive ability or quality of life in primary hyperparathyroidism patients 2.

Prognosis

Untreated hypercalcemic crisis carries 100% mortality; conservative treatment alone has 93.5% mortality 7. Medical therapy followed by expeditious parathyroidectomy is the treatment of choice 7. The prognosis for asymptomatic primary hyperparathyroidism is excellent with either surgical or medical management 3.

Place of Care

• Critical care unit admission required for: severe clinical manifestations (altered consciousness, dehydration with acute renal failure, severe pancreatitis), threatening ECG signs, or significant cardiovascular comorbidities 1
• Conventional or critical care unit for calcium ≥3.5 mmol/L, depending on symptoms and comorbidities 1